Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the percent reduction in the rate of febrile reactions when prophylactic antipyretic treatment is administered relative to no prophylactic antipyretic treatment after vaccination with a 7-valent pneumococcal conjugate vaccine (7vPnC, Prevenar®) and routine DTPa-HBV-IPV+Hib (Infanrix hexa®) vaccination at 2, 3, 4 (primary series) and 11-14 (booster dose) months of age.
Critère d'inclusion
- Healthy infants who shall receive their first routine vaccination